Evaluation of residual tissues after adjuvant therapy in germ cell tumors

Pediatric Neurosurgery

Volumn 43, Issue 2, 2007, Pages 82-91

  Nakamura, Hideo ^a   Takeshima, Hideo ^a   Makino, Keishi ^a   Kuratsu, Jun Ichi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Adjuvant therapy; Adjuvant therapy, residual tissue evaluation; Germ cell tumors; Germinomas; Non germinomatous malignant germ cell tumors; Pediatric CNS tumors; Residual tissues, evaluation; Syncytiotrophoblastic giant cells

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE;

ADOLESCENT; ADULT; ARTICLE; CALCIFICATION; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CELL VIABILITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GERM CELL TUMOR; GIANT CELL TUMOR; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; NECROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATHOLOGY; PINEAL BODY TUMOR; PRIORITY JOURNAL; SECOND LOOK SURGERY; TERATOMA; TREATMENT DURATION; TUMOR DIAGNOSIS; YOLK SAC;

ADOLESCENT; ADULT; ANTINEOPLASTIC PROTOCOLS; BIOPSY; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; GIANT CELLS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; NEOPLASMS, GERM CELL AND EMBRYONAL; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE; TROPHOBLASTS;

EID: 33847390732     PISSN: 10162291     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098378     Document Type: Article

References (24)

1. Kuratsu J, Ushio Y: Epidemiological study of primary intracranial tumors in childhood. A population-based survey in Kumamoto Prefecture, Japan. Pediatr Neurosurg 1996;25:240-246.
2. Kuratsu J, Ushio Y: Epidemiological study of primary intracranial tumors: a regional survey in Kumamoto Prefecture in the southern part of Japan. J Neurosurg 1996;84:946-950.
3. Hardenbergh PH, Golden J, Billet A, Scott RM, Shrieve DC, Silver B, Loeffler JS, Tarbell NJ: Intracranial germinoma: the case for lower dose radiation therapy. Int J Radiat Oncol Biol Phys 1997;39:419-426.
4. Shibamoto Y, Sasai K, Oya N, Hiraoka M: Intracranial germinoma: radiation therapy with tumor volume-based dose selection. Radiology 2001;218:452-456.
5. Baranzelli MC, Patte C, Bouffet E, Couanet D, Habrand JL, Portas M, Lejars O, Lutz P, Le Gall E, Kalifa C: Nonmetastatic intracranial germinoma: the experience of the French Society of Pediatric Oncology. Cancer 1997;80:1792-1797.
6. Buckner JC, Peethambaram PP, Smithson WA, Groover RV, Schomberg PJ, Kimmel DW, Raffel C, O'Fallon JR, Neglia J, Shaw EG: Phase II trial of primary chemotherapy followed by reduced-dose radiation for CNS germ cell tumors. J Clin Oncol 1999;17:933-940.
7. Sawamura Y, Ikeda J, Shirato H, Tada M, Abe H: Germ cell tumours of the central nervous system: treatment consideration based on 111 cases and their long-term clinical outcomes. Eur J Cancer 1998;34:104-110.
8. Robertson PL, DaRosso RC, Allen JC: Improved prognosis of intracranial non-germinoma germ cell tumors with multimodality therapy. J Neurooncol 1997;32:71-80.
9. Jennings MT, Gelman R, Hochberg F: Intracranial germ-cell tumors: natural history and pathogenesis. J Neurosurg 1985;63:155-167. 10 Matsutani M, Sano K, Takakura K, Fujimaki T, Nakamura O: Combined treatment with chemotherapy and radiation therapy for intracranial germ cell tumors. Childs Nerv Syst 1996;14:59-62.
10. Matsutani M: Combined chemotherapy and radiation therapy for CNS germ cell tumors - the Japanese experience. J Neurooncol 2001;54:311-316.
11. Ushio Y, Kochi M, Kuratsu J, Itoyama Y, Marubayashi T: Preliminary observations for a new treatment in children with primary intracranial yolk sac tumor or embryonal carcinoma. Report of five cases. J Neurosurg 1999;90:133-137.
12. Kochi M, Itoyama Y, Shiraishi S, Kitamura I, Marubayashi T, Ushio Y: Successful treatment of intracranial nongerminomatous malignant germ cell tumors by administering neoadjuvant chemotherapy and radiotherapy before excision of residual tumors. J Neurosurg 2003;99:106-114.
13. Muller AM, Ihorst G, Waller CF, Dolken G, Finke J, Engelhardt M: Intensive chemotherapy with autologous peripheral blood stem cell transplantation during a 10-year period in 64 patients with germ cell tumor. Biol Blood Marrow Transplant 2006;12:355-365.
14. Robison LL, Nesbit ME Jr, Sather HN, Level C, Shahidi N, Kennedy A, Hammond D: Down syndrome and acute leukemia in children: a 10-year retrospective survey from Children's Cancer Study Group. J Pediatr 1984;105:235-242.
15. Chessells JM, Harrison G, Richards SM, Bailey CC, Hill FG, Gibson BE, Hann IM: Down's syndrome and acute lymphoblastic leukaemia: clinical features and response to treatment. Arch Dis Child 2001;85:321-325.
16. Satge D, Monteil P, Sasco AJ, Vital A, Ohgaki H, Geneix A, Malet P, Vekemans M, Rethore MO: Aspects of intracranial and spinal tumors in patients with Down syndrome and report of a rapidly progressing Grade 2 astrocytoma. Cancer 2001;91:1458-1466.
17. Dieckmann KP, Rube C, Henke RP: Association of Down's syndrome and testicular cancer. J Urol 1997;157:1701-1704.
18. Satge D, Sasco AJ, Chompret A, Orbach D, Mechinaud F, Lacour B, Roullet B, Martelli H, Bergeron C, Bertrand Y, Lacombe D, Pe rel Y, Monteil P, Nelken B, Bertozzi AI, Munzer M, Kanold J, Bernard F, Vekemans MJ, Sommelet D: A 22-year French experience with solid tumors in children with Down syndrome. Pediatr Hematol Oncol 2003;20:517-529.
19. Yarden Y, Kuang WJ, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, Chen E, Schlessinger J, Francke U, Ullrich A: Human protooncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 1987;6:3341-3351.
20. Shearman MS, Herbst R, Schlessinger J, Ullrich A: Phosphatidylinositol 3′-kinase associates with p145c-kit as part of a cell type characteristic multimeric signalling complex. EMBO J 1993;12:3817-3826.
21. Miyanohara O, Takeshima H, Kaji M, Hirano H, Sawamura Y, Kochi M, Kuratsu J: Diagnostic significance of soluble c-kit in the cerebrospinal fluid of patients with germ cell tumors. J Neurosurg 2002;97:177-183.
22. Takeshima H, Kuratsu J: A review of soluble c-kit (s-kit) as a novel tumor marker and possible molecular target for the treatment of CNS germinoma. Surg Neurol 2003;60:321-324.
23. Nakamura H, Takeshima H, Makino K, Kuratsu J: c-kit expression in germinoma: an immunohistochemistry-based study. J Neurooncol 2005;75:163-167.
24. De Santis M, Pont J: The role of positron emission tomography in germ cell cancer. World J Urol 2004;22:41-46.